Robin Stuart Buckle

Lazard & Co. Ltd. provides investment banking services. The company offers its services for corporations, partnerships, institutions, governments and high-net worth individuals. The company operates in approximately 29 cities in key business and financial centers across 16 countries in Europe, North America, Asia, Australia and South America. The company is located in London, UK.

Crest Nicholson is a leading developer of sustainable communities whose mission is to be the market leader in the design and delivery of sustainable housing and mixed use communities. Their aim to improve the quality of life for individuals and communities, both now and in the future, by providing better homes, work places, retail and leisure spaces. Its ongoing emphasis on environmentally responsible housing and commitment to deliver truly low carbon sustainable schemes is evidenced by an ever increasing development portfolio. Its vision and values in design, customer service, innovation and environmental stewardship equip the Group well to lead in the complex and challenging process of delivering communities both now and in the future.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006.

Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom.

BIAL-Portela & Cia SA manufactures pharmaceutical products. It develops drugs in therapeutic areas such as antibiotics, anti-inflammatory, anti-ulcer, anti-depressants, anti-asthmatic, and analgesics. The firm also offers anti-allergic vaccines and the means of diagnosing allergies. It has two production plants and two R&D centers in the Porto area and in Bilbao, Spain. The company was founded by António Portela in 1924 and is headquartered in Coronado, Portugal.

B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany.

NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom.

Part of Thermo Fisher Scientific, Inc., Oxoid International Ltd. is a holding British company that offers diagnostic products to microbiology laboratories. The company is based in Altrincham, UK.

Home Start UK is a local community network that provides trained volunteers and expert support to help families with young children through their challenging times. The non-profit company is based in Leicester, UK. The organization has a directory of its own research and external studies on the impact of its work. By raising funds for Home Start, donors can help thousands of struggling families and give their children the best possible start in life. The fundraising team is available to support donors in their efforts. The CEO of the British company is Peter Grigg.

Alzheimer's Research UK is a leading charity based in Cambridge, UK, that was founded in 1992 and is headed by CEO Hilary Evans. Alzheimer's Research UK is forging partnerships at home and across the globe to defeat dementia sooner. The organization specializes in finding preventions, treatments, and a cure for dementia. The British company currently supports pioneering dementia research projects worth nearly £34 million in leading universities across the UK. The charity funds and delivers pioneering research to revolutionize the way we treat, diagnose, and prevent dementia. The non-profit company stands for everyone affected by dementia and aim to find a cure for the disease. The organization challenges perceptions of dementia using an orange and encourages people to share a better understanding of the disease.

Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom.

Part of Essent Netwerk Facilities Zuid BV, Edon is a Dutch company that provides electric services. The company is based in Zwolle, the Netherlands. Edon was acquired by Essent Netwerk Facilities Zuid BV on January 01, 1999.

London & Partners Ltd. is a business growth and destination agency based in London, UK. and has subsidiaries in United Kingdom. The British company's mission is to create economic growth that is resilient, sustainable and inclusive. The private company was founded in 2011. Laura Citron has been the CEO of the company since 2017.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Lazard Group LLC provides financial advisory, asset management, and other financial services. The firm offers services related to mergers and acquisitions, strategic advisory, middle market advisory, capital markets and capital structure advisory, sovereign advisory, restructuring, and private fund advisory. The company was founded in 1840 and is headquartered in New York, NY.

Part of Lazard Ltd., Lazard & Co. Holdings Ltd. is a financial advisory and British investment solutions company. The company is based in London, UK. The company's mission is to provide trusted and independent financial advice to its clients, backed by the intellectual capital of the firm. Lazard has been a leading advisor to debtors and creditors in the world's largest and most complex restructurings for decades.

Part of Lazard Ltd., Lazard & Co. Services Ltd. is a financial advisory company based in London, UK. Lazard provides research and special reports on key events driving the financial markets, with a focus on asset management and financial advisory. The British company's mission is to provide trusted and independent financial advice and investment solutions to clients, backed by the intellectual capital of their firm. Lazard specializes in advisory services, including sovereign advisory, geopolitical advisory, and climate center.

Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA.

GlaxoSmithKline Pharmaceuticals SA develops and manufactures pharmaceuticals and vaccines. The company is headquartered in Wavre, Belgium.

Part of UCB SA, Celltech Group Ltd. is an investment holding British company. The company is based in Slough, UK. Celltech Group was founded in 1987.